Gabelli Healthcare & WellnessRx Trust (Gabelli Healthcare & WellnessRx Trust) Sloan Ratio % : 0.00% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Gabelli Healthcare & WellnessRx Trust Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Gabelli Healthcare & WellnessRx Trust's Sloan Ratio for the quarter that ended in Dec. 2023 was 0.00%.

As of Dec. 2023, Gabelli Healthcare & WellnessRx Trust has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.

Gabelli Healthcare & WellnessRx Trust Sloan Ratio % Historical Data

The historical data trend for Gabelli Healthcare & WellnessRx Trust's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gabelli Healthcare & WellnessRx Trust Sloan Ratio % Chart

Gabelli Healthcare & WellnessRx Trust Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Sloan Ratio %

Get a 7-Day Free Trial

Gabelli Healthcare & WellnessRx Trust Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Sloan Ratio %	Get a 7-Day Free Trial								-	-	-	-	-

Competitive Comparison of Gabelli Healthcare & WellnessRx Trust's Sloan Ratio %

For the Asset Management subindustry, Gabelli Healthcare & WellnessRx Trust's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gabelli Healthcare & WellnessRx Trust's Sloan Ratio % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Gabelli Healthcare & WellnessRx Trust's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Gabelli Healthcare & WellnessRx Trust's Sloan Ratio % falls into.

Gabelli Healthcare & WellnessRx Trust Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Gabelli Healthcare & WellnessRx Trust's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio	=	(Net Income (A: Dec. 2023 )	-	Cash Flow from Operations (A: Dec. 2023 )
	-	Cash Flow from Investing (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2023 )
	=	(0.423	-	6.607
	-	0)	/	239.044
	=	-2.59%

Gabelli Healthcare & WellnessRx Trust's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio	=	(Net Income (TTM)	-	Cash Flow from Operations (TTM))
	-	Cash Flow from Investing (TTM))	/	Total Assets (Q: Dec. 2023 )
	=	(0.423	-	6.607
	-	0)	/	239.044
	=	-2.59%

For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data. Gabelli Healthcare & WellnessRx Trust's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 4.798 (Jun. 2023 ) + -4.375 (Dec. 2023 ) = $0.42 Mil.
Gabelli Healthcare & WellnessRx Trust's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was -15.171 (Jun. 2023 ) + 21.778 (Dec. 2023 ) = $6.61 Mil.
Gabelli Healthcare & WellnessRx Trust's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was 0 (Jun. 2023 ) + 0 (Dec. 2023 ) = $0.00 Mil.

Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Gabelli Healthcare & WellnessRx Trust has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.

Gabelli Healthcare & WellnessRx Trust Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Gabelli Healthcare & WellnessRx Trust's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gabelli Healthcare & WellnessRx Trust (Gabelli Healthcare & WellnessRx Trust) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) » Definitions » Sloan Ratio %

Comparable Companies

Traded in Other Exchanges

N/A

Address

One Corporate Center, Rye, NY, USA, 10580-1422

Website

https://www.gabelli.com

Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least 80% of its assets in equity securities and income-producing securities of domestic & foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.

Executives

Mario J Gabelli	director	191 MASON STREET, GREENWICH CT 06830
Agnes Mullady	director	ONE CORPORATE CENTER, RYE NY 10580
Calgary Avansino	director	C/O GAMCO INVESTORS, INC., ONE CORPORATE CENTER, RYE NY 10580
Leslie Fahrenkopf Foley	director	C/O GAMCO INVESTORS, INC., ONE CORPORATE CENTER, RYE NY 10580
Jonas Jeffrey J. Jr	director	C/O GAMCO INVESTORS, INC., ONE CORPORATE CENTER, RYE NY 10580
Peter D. Goldstein	officer: Secretary	249 ROYAL PALM WAY, SUITE 503, PALM BEACH FL 33480
James P Conn	director
John Chester Ball	officer: Treasurer	800 CONNECTICUT AVENUE, NORWALK CT 06854
Kuni Nakamura	director	1 MARTIN BUTLER COURT, RYE NY 10580
Joseph H Egan	officer: Treasurer	ONE CORPORATE CENTER, RYE NY 10580
Bruce N Alpert	officer: Acting President/Treasurer	C/O GAMCO INVESTORS, INC., ONE CORPORATE CENTER, RYE NY 10580
Thomas E Bratter	director	ONE CORPORATE CENTER, RYE NY 10580
Salvatore J Zizza	director	810 SEVENTH AVE, 27TH FLOOR, NEW YORK NY 10019
Gpj Retirement Partners, Llc	other: Limited Liability Company	1 CORPORATE CENTER, RYE NY 10580
Mjg Iv Limited Partnership	other: Limited Partnership